Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Mar 2026 for Jazz Pharmaceuticals plc, €424k.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Philip L. Johnson: trading record in brief
Philip L. Johnson discloses dealings in Jazz Pharmaceuticals plc to SEC (Form 4). The record holds 7 filings, for trades running from 1 March 2024 to 5 March 2026.
No open-market sale appears; the market trades are 1 purchase worth €1.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 5 share grants.
The latest filing, published on 9 March 2026, reports a share grant of €424k in Jazz Pharmaceuticals plc. The latest purchase dates back some time: it was published 962 days ago, on 5 March 2024. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Philip L. Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
2,615 shares@ US$188.6973.8% of flowOrdinary SharesSEC:0002013156-26-000004:0
11,857 shares0Ordinary SharesSEC:0002013156-26-000002:0
1,149 shares@ US$138.9526.2% of flowOrdinary SharesSEC:0001765581-25-000027:0
15,407 shares0Ordinary SharesSEC:0001765581-25-000012:0
15,932 shares0Ordinary SharesSEC:0001765581-24-000009:0
5 of 5 declarations
